Published Date: 17 Feb 2023
Many patients with ANCA-associated autoimmune vasculitis (AAV) are at risk of disease recurrence despite treatment. Researchers at the Karolinska Institutet have just identified a T cell that contributes to the destruction of...
Read Full News1.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
2.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
3.
Year in Review: Multiple Myeloma
4.
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
5.
Could semaglutide be used to treat addiction in addition to obesity?
1.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
2.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
3.
Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial
4.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
5.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation